Rb's unexpected activation of estrogen-responsive genes could explain breast cancer treatment resistance

Дата публикации: 13-08-2026 20:20:03

Researchers at Peter Mac have discovered why breast cancer treatment stops working for some patients, uncovering the unexpected role of one of the body's most important cancer-fighting proteins. The study, published in Nature, revealed that the retinoblastoma (Rb) protein—long considered one of the body's natural brakes on cancer growth—has a more complex function than previously understood.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	A hidden weakness in deadly cancers could lead to powerful new treatments	0	7.28	04-07-2026
2	Gut bacteria may influence estrogen-related cancers, review finds	0	5	06-07-2026
3	Gut bacteria may influence estrogen-related cancers, review finds	0	7	06-07-2026
4	Breast cancers can recruit bone cells to increase tumor growth	0	8.49	14-08-2026
5	Regional differences in chemotherapy treatment for breast cancer may affect survival, Swedish study finds	0	6.96	13-08-2026
6	В России разработали ПЦР-тест для оценки агрессивности рака	5	7	02-07-2026
7	Anti-Müllerian hormone predicts benefit of chemo + endocrine therapy in under-55s with breast cancer	0	12.26	12-08-2026
8	Scientists discover why cancer drugs don’t work for everyone	0	7.7	27-03-2026
9	Tiny BAP1 mutations can disrupt internal signals that suppress tumor growth	0	12.72	24-07-2026
10	Cancer protein p53 observed in action reveals more order than expected	0	5.33	12-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 8.64. Источник: medicalxpress.com.